Themis Medicare Limited filed a Writ Petition before the Delhi High Court in 2024 challenging CMSS’s tender process and the rejection of its technical bid for Rifapentine 150 mg. The petition was later withdrawn with liberty, with the Court clarifying that the petitioner’s pending departmental remedies would remain unaffected.
This website is for informational purposes only and is not intended to advertise or solicit work as per the Bar Council of India rules. By accessing www.foresightlawoffices.com, you acknowledge that you are seeking information about Foresight Law voluntarily. Nothing on this site constitutes legal advice or creates a lawyer-client relationship. Foresight Law is not responsible for any actions taken based on the content here. External links do not imply endorsement. Please do not share confidential information via this website. For details, review our Privacy Policy and Terms of Use.